CD40LG and infection: CSR occurs in vivo following immunization or infection and enables antigen-activated, IgM+-expressing B cells to change the constant domains of Igμ heavy chains, hence the expression of novel isotypes (IgG, IgE, or IgA) with different effector functions (11–13).